Swiss Firmenich has agreed to buy Les Dérivés Résiniques et Terpéniques (DRT), which specialises in plant-based chemistry, from private equity group Ardian, Tikehau Capital and family shareholders, the flavours and fragrances group said on Friday.
It gave no financial terms for buying DRT, which has more than 550 million euros ($620 million) in sales, over 1,500 employees and production sites in France, the United States, India and China.
It specialises in naturally derived ingredients, mainly from pine trees.
Firmenich Chief Executive Gilbert Ghostine said DRT would strengthen Firmenich’s perfumery & ingredients business.
“DRT would bring new capabilities in health & nutrition, cosmetics, as well as a number of new markets, including adhesives, coatings and agriculture,” he said.
Goldman Sachs and Raphael Financial Advisory advised Firmenich, while buyer due diligence was provided by Deloitte Finance, Bredin Prat and Taj Avocats, Firmenich said.
Citi and Rothschild & Co advised Adrian, while Latham & Watkins provided legal advice. Due diligence advisers were EY Finance, White & Case, Advancy, Ramboll, EY Tax and Indefi.
Source: Reuters
Can’t stop reading? Read more
Rightsizing the right way
Rightsizing the right way Rightsizing an organization is never easy. But, it is a normal process...
Mozaik Investments acquires majority stake in Romania’s Genesis College, plans €30m expansion
Mozaik Investments acquires majority stake in Romania’s Genesis College, plans €30m expansion...
Pimco and KKR in talks to acquire $5bn stake in Harley-Davidson’s finance unit
Pimco and KKR in talks to acquire $5bn stake in Harley-Davidson’s finance unit Harley-Davidson is...